Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
100751-63-1
18982-54-2
191529-08-5
873-75-6
168886-97-3
56052-26-7
29278-72-6 | 3,8,15,20,27,32,39,44-Octaoxapentacyclo[44.2.2.210,13.222,25.234,37]hexapentaconta-10,12,22,24,34,36,46,48,49,51,53,55-dodecaene-2,9,14,21,26,33,38,45-octone | AA00BGJ1
221199-31-1 | N-[3-(4-AMINO-2-FLUOROPHENOXY)PROPYL]-N,N-DIMETHYLAMINE | AA00BGWY | MFCD08686806
200878-50-8 | 2-Bromo-7-methoxy-9h-carbazole | AA00BHAP | MFCD19288761
256931-54-1 | 3-Methylazetidin-3-ol | AA00BHNN | MFCD10565787
24187-83-5 | 2,3,4,5-Tetrahydrobenzo[f][1,4]thiazepine 1,1-dioxide hydrochloride | AA00BI0B | MFCD22376718
2382-56-1 | Phenolphthalein diphosphate pentasodium salt hydrate | AA00BIBR | MFCD28386115
234750-98-2 | Methyl 4-(cyclopentylamino)-3-nitrobenzoate | AA00BIEL | MFCD14281680
226085-18-3 | 3-Bromo-1-tosyl-1h-pyrrolo[2,3-b]pyridine | AA00BIQB | MFCD10697518
2727-71-1 | AcetaMide, N-(2-broMophenyl)-2,2,2-trifluoro- | AA00BJ1I | MFCD00595489
204856-73-5 | Boc-4-acetyl-l-phenylalanine | AA00BJGP | MFCD01632035
74411-22-6
141336-05-2
1353983-85-3
40039-93-8
2415603-54-0
443330-01-6
Journal: Bioorganic & medicinal chemistry letters20101101